Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension.

RT, Zamanian; H, Hedlin; P, Greuenwald; DM, Wilson; JI, Segal; M, Jorden; K, Kudelko; J, Liu; A, Hsi; A, Rupp; AJ, Sweatt; R, Tuder; GJ, Berry; M, Rabinovitch; RL, Doyle; Jesus Perez V, de; SM, Kawut

doi:10.1164/rccm.201705-0943oc

Public

Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension.

Shared by NobleBlocks on Mar 1, 2018 • 12:00 AM UTC

Authors:

Zamanian RT

Hedlin H

Greuenwald P

Abstract

Rationale Although amphetamines are recognized as "likely" agents to cause drug- and toxin-associated pulmonary arterial hypertension (PAH), (meth)amphetamine-associated PAH (Meth-APAH) has not been well described.Objectives To prospectively characterize the clinical presentation, histopathology, an...

Subject

methamphetamine

Outcomes

Pulmonary Arterial Hypertension

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!